['wound infection']
['e. coli phages cocktail', 'standard of care : silver sulfadiazine', 'p. aeruginosa, phages cocktail']

        Inclusion Criteria:

          -  Man or woman

          -  Adult Informed consent obtained from patient or next of kin

          -  In-hospital patient treated for burn wounds in a burn unit

          -  Burn wound (grafted or not) or graft harvesting area, presenting local signs of
             infection defined by SFETB criteria:

               -  A local or loco-regional inflammatory reaction;

               -  And/or an adverse and unexpected local evolution;

               -  And/or regarding burn wounds: presence of pus, fast spontaneous debridement and
                  separation, occurrence of blackish spots (necrosis or haemorrhage), unexplained
                  conversion from a superficial lesion to a deep one (> 48th hour);

               -  And/or regarding graft donor sites: presence of pus, unexplained delay in
                  epidermisation, bedsore;

               -  And/or regarding graft recipient sites: presence of pus, lysis of grafts,
                  necrosis of fat located under the graft.

          -  Burn wounds with a microbiologically documented infection, as defined by positive
             surface swab, due to Escherichia coli or Pseudomonas aeruginosa whatever their
             resistance profile

          -  Treated by povidone-iodine

        Exclusion Criteria:

          -  Pregnant or breastfeeding woman

          -  Intercurrent condition requiring a treatment which may interfere with analysis
             results: such as high dose of chronic corticotherapy, immunosuppressive medication,
             oncologic chemotherapy

          -  Patient included in an interventional research protocol with therapeutic intervention
             still ongoing upon inclusion time or having participated into anti-infective drug
             trials during the previous month.

          -  Patient considered as part of a vulnerable population

          -  Patient for whom treatment limitation or withdrawal during study period is considered

          -  Allergy to Silver Sulfadiazine
      